In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at British Patient Capital (BPC), discussing the vitally hot topic of investment in life sciences.
Real-world evidence and qualitative research: the ELICIT podcast
Merck on trends in oncology: the pharmaphorum podcast
Sandoz’s Pierre Bourdage on biosimilars: the pharmaphorum podcast
Patient engagement strategies: the pharmaphorum podcast
BMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcast
Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcast
Virtual engagement and collaborations: the pharmaphorum podcast
Biotech Insight podcast: Overcoming planning challenges in oncology
Vertex senior country manager Nicola Massey: the pharmaphorum podcast
Regenerative medicine and COVID: the pharmaphorum podcast
Pharmacy and clinical research: the pharmaphorum podcast
Pharma’s post-COVID prospects: the pharmaphorum podcast
Galapagos UK’s Michael Smyth on COVID and RNA-based tech: the pharmaphorum podcast
Big data and cell therapy development: the pharmaphorum podcast
GSK on COVID and vaccine development: the pharmaphorum podcast
The meaning of digital innovation: the pharmaphorum podcast
New ways to treat COVID: the pharmaphorum podcast
The Alderley Park Discovery Podcast: The journey to accessing science funding and investment
Roche on COVID healthcare and testing: the pharmaphorum podcast
Richard Francis discusses his new role as Purespring’s CEO: pharmaphorum podcast
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Unexplainable
Stuff To Blow Your Mind
Speaking of Psychology